Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT

Ovid Therapeutics Statistics

Share Statistics

Ovid Therapeutics has 71.11M shares outstanding. The number of shares has increased by 0.19% in one year.

71.11M
0.19%
0.05%
31.09%
59.51M
2,834
0.18%

Short Selling Information

The latest short interest is 1.04M, so 1.47% of the outstanding shares have been sold short.

1.04M
1.47%
1.75%
1.07

Valuation Ratios

The PE ratio is -2.5 and the forward PE ratio is -0.8. Ovid Therapeutics's PEG ratio is 0.05.

-2.5
-0.8
116.97
119.8
0.97
-1.18
0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ovid Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.22.

5.32
5.32
0.22
-0.24
-0.26
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$24.61K
$-1.15M
23
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -33.72% in the last 52 weeks. The beta is 0.21, so Ovid Therapeutics's price volatility has been higher than the market average.

0.21
-33.72%
0.41
0.62
54.82
1,554,769

Income Statement

In the last 12 months, Ovid Therapeutics had revenue of 566K and earned -26.43M in profits. Earnings per share was -0.37.

566K
566K
-61.88M
-26.43M
-61.27M
-58.38M
-0.37
Full Income Statement

Balance Sheet

The company has 26.3M in cash and 14.76M in debt, giving a net cash position of 11.55M.

26.3M
14.76M
11.55M
-304.3M
81.65M
36.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -55.96M and capital expenditures -71K, giving a free cash flow of -56.03M.

-55.96M
-71K
-56.03M
-0.79
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -10933.75% and -4670.14%.

100%
-10933.75%
-4670.14%
-4670.14%
-10825.27%
-10933.75%
-9898.76%

Dividends & Yields

OVID does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for OVID is $3.5, which is 525% higher than the current price. The consensus rating is "Buy".

$3.5
525%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-6.17
3